Schellenberg GD

References (4)

Title : Neuropsychiatric Symptoms and Caregiver Burden in Individuals With Alzheimer's Disease: The TEAM-AD VA Cooperative Study - Chen_2018_J.Geriatr.Psychiatry.Neurol__891988718783897
Author(s) : Chen P , Guarino PD , Dysken MW , Pallaki M , Asthana S , Llorente MD , Love S , Vertrees JE , Schellenberg GD , Sano M
Ref : J Geriatr Psychiatry Neurol , :891988718783897 , 2018
Abstract :
PubMedSearch : Chen_2018_J.Geriatr.Psychiatry.Neurol__891988718783897
PubMedID: 29966477

Title : Effect of vitamin E and memantine on functional decline in Alzheimer disease: the TEAM-AD VA cooperative randomized trial - Dysken_2014_JAMA_311_33
Author(s) : Dysken MW , Sano M , Asthana S , Vertrees JE , Pallaki M , Llorente M , Love S , Schellenberg GD , McCarten JR , Malphurs J , Prieto S , Chen P , Loreck DJ , Trapp G , Bakshi RS , Mintzer JE , Heidebrink JL , Vidal-Cardona A , Arroyo LM , Cruz AR , Zachariah S , Kowall NW , Chopra MP , Craft S , Thielke S , Turvey CL , Woodman C , Monnell KA , Gordon K , Tomaska J , Segal Y , Peduzzi PN , Guarino PD
Ref : Jama , 311 :33 , 2014
Abstract :
PubMedSearch : Dysken_2014_JAMA_311_33
PubMedID: 24381967

Title : The correlation of paraoxonase (PON1) activity with lipid and lipoprotein levels differs with vascular disease status - Rozek_2005_J.Lipid.Res_46_1888
Author(s) : Rozek LS , Hatsukami TS , Richter RJ , Ranchalis J , Nakayama K , McKinstry LA , Gortner DA , Boyko E , Schellenberg GD , Furlong CE , Jarvik GP
Ref : J Lipid Res , 46 :1888 , 2005
Abstract :
PubMedSearch : Rozek_2005_J.Lipid.Res_46_1888
PubMedID: 15995178

Title : Analysis of paraoxonase (PON1) L55M status requires both genotype and phenotype - Brophy_2000_Pharmacogenet_10_453
Author(s) : Brophy VH , Jarvik GP , Richter RJ , Rozek LS , Schellenberg GD , Furlong CE
Ref : Pharmacogenetics , 10 :453 , 2000
Abstract :
PubMedSearch : Brophy_2000_Pharmacogenet_10_453
PubMedID: 10898114